SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950142-13-001759
Filing Date
2013-08-07
Accepted
2013-08-07 06:02:03
Documents
1
Group Members
GLENVIEW CAPITAL MANAGEMENT LLCLAWRENCE M. ROBBINS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 eh1301000_13da1-kvphar.htm SC 13D/A 214589
  Complete submission text file 0000950142-13-001759.txt   216255
Mailing Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146
Business Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-12338 | Film No.: 131015669
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153 2128124700
GLENVIEW CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001138995 (see all company filings)

IRS No.: 134136746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A